Speakers

Antibody Engineering Stream Speakers | Protein Expression Stream Speakers | Protein Expression Stream Speakers 

Keynote Speakers 

  • Luis Borges, Ph.D., Scientific Director, Therapeutic Innovation Unit, Amgen, Inc.
  • Yves Durocher, Ph.D., Protein Expression Team Leader, Life Sciences, NRC Human Health Therapeutics Portfolio, National Research Council Canada
  • Dominic Esposito, Ph.D., Director, Protein Expression Laboratory, SAIC-Frederick
  • Robert Lutz, Ph.D., Vice President, Translational Research & Development, ImmunoGen, Inc.
  • Martine Piccart, M.D., Ph.D., Head, Medical Oncology, Jules Bordet Institute; Chair, ESMO (European Society for Medical Oncology)
  • Andreas Plückthun, Ph.D., Director and Professor, Biochemistry, University of Zurich

Antibody Engineering Stream Speakers 

  • Stefan Dübel, Ph.D., Director, Biotechnology and Bioinformatics, Institute of Biochemistry, Technische Universität Braunschweig
  • Stefan Ewert, Ph.D., Senior Investigator, NIBR Biologics Center, Novartis Pharma AG
  • Shohei Koide, Ph.D., Professor, Biochemistry and Molecular Biology, University of Chicago
  • Jim Freeth, Ph.D., Managing Director, Retrogenix, UK
  • Andrew Henry, Chemical Computing Group
  • David Lowe, Ph.D., Fellow, Research & Development, Antibody Discovery and Protein Engineering, MedImmune LLC
  • Oliver Hill, Ph.D., Vice President, Molecular Biology, Apogenix GmbH
  • Javier Chaparro-Riggers, Associate Research Fellow, Protein Engineering, Rinat-Pfizer, Inc.
  • Arne Skerra, Ph.D., Professor, Technische Universität Munich; Co-Founder, Pieris AG, Germany
  • Janine Schuurman, Ph.D., Director, Strategic Research, Genmab B.V.
  • Johan Nilvebrant, Ph.D., Post-Doctoral Researcher, Protein Technology, Royal Institute of Technology, Alba Nova University Center, Stockholm
  • Vera Molkenthin, Ph.D., Chief Scientist, AbCheck s.r.o
  • Robert Mabry, Ph.D., Associate Director, Antibody Discovery and Bispecific Engineering, Adimab LLC
  • John Haurum, CEO, F-star
  • Ulrich Brinkmann, Ph.D., Senior Principal Scientist, Pharma Research and Early Development (pRED), Large Molecule Research, Roche Penzberg
  • Ton Logtenberg, Ph.D., CEO, Merus B.V.
  • Andres Männik, Ph.D., CTO, Icosagen Cell Factory Ltd
  • Germaine Fuh, Ph.D., Senior Scientist, Antibody Engineering, Genentech, Inc.
  • Jason Baum, Ph.D., Principal Scientist, Research, Merrimack Pharmaceuticals, Inc.
  • Nicolas Fischer, Ph.D., Head, Research, Novimmune SA
  • Alessandro Angelini, Ph.D., David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT)
  • Michael Kragh, Ph.D., Director, Antibody Pharmacology, Symphogen A/S
  • Andrea van Elsas, CSO, BioNovion B.V.
  • Laura Gualandi, Ph.D., Philochem A.G.
  • Robert Mashal, CEO, NKT Therapeutics
  • Ekkehard Moessner, Ph.D., Group Leader, Protein Engineering, pRED, Roche Glycart A.G.
  • Timothy B. Lowinger, Ph.D., CSO, Mersana Therapeutics, Inc.
  • David Jackson, Ph.D., Principle Scientist, ADC Discovery, Igenica, Inc.
  • Pavel Strop, Ph.D., Associate Research Fellow, Protein Engineering, Rinat- Pfizer, Inc.
  • Marion Blomenröhr, Ph.D., Program Manager Biopharmaceuticals, Synthon Biopharmaceuticals
  • Antony Godwin, Ph.D., Director, Science & Technology, PolyTherics Ltd.
  • Hubert Kettenberger, Ph.D., Principal Scientist, Large Molecule Research, Roche Pharma Research and Early Development (pRED)
  • Bernhard Helk, Ph.D., Head, New Technologies, Biologics, Novartis Pharma AG
  • Jonas V. Schaefer, Ph.D., High-Throughput Laboratory, Biochemistry, University of Zurich
  • Trevor J. Hallam, Ph.D., CSO, Research & Development, Sutro Biopharma, Inc.
  • Arieh Gertler, Ph.D., Professor, Institute of Biochemistry, Food Science and Nutrition, Hebrew University in Jerusalem
  • Birgit Bossenmaier, Ph.D., Principle Scientist, Discovery Oncology, Roche
  • Noam Shani, M.D., KAHR Medical, Hadassah Medical Center, Jerusalem
  • Syd Johnson, Ph.D., Vice President, Antibody Engineering, MacroGenics, Inc.
  • Ignacio Dolado, Ph.D., Program Leader, Research Oncology, Molecular Partners A.G.
  • Tariq Ghayur, Ph.D., Senior Research Fellow, DVD – Ig & Novel Biologics, Abbvie, Inc.
  • Steven Grant, Ph.D., Manager, Biopharm Discovery, Biopharm Research & Development, GSK (Domantis)
  • Kathleen Hefferon, Ph.D., Scientist, Cell and Systems Biology, University of Toronto
  • John W. Blankenship, Ph.D., Principal Scientist, Applied Research, Emergent Biosolutions
  • Jim Freeth, Ph.D., Managing Director, Retrogenix, UK
  • Maria Wendt, Ph.D., Senior Scientific Consultant, Biologics, Genedata
  • Jan Van Den Brulle, Ph.D., Director, Discovery Alliances Technologies, MorphoSys AG
  • Roman Kischel, M.D., BiTE Technology, Amgen Research (Munich) GmbH

Protein Expression Stream Speakers 

  • Bernadette Byrne, Ph.D., Professor, Division of Molecular Biosciences, Imperial College London
  • Jonas Schaefer, Ph.D., Head, High-Throughput Laboratory, Department of Biochemistry, University of Zurich
  • Bruno Coutard, Ph.D., Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR CNRS and Aix-Marseille University
  • E. Neil Lewis, CTO, Malvern Instruments & Head, Malvern Bioscience Development Initiative
  • Scott Lesley, Ph.D., Director, Protein Sciences and Biotherapeutics, Genomics Institute of the Novartis Research Foundation
  • Eric R. Geertsma, Ph.D., Department of Biochemistry, University of Zurich
  • Louise E. Bird, Ph.D., Division of Structural Biology, Henry Wellcome Building for Genomic Medicine, University of Oxford
  • Philippe Mondon, Ph.D., CTO, MILLEGEN SA
  • Jacques Dumas, Ph.D., Head, Protein Production, Vitry Biologics SCP, Vitry Research Center, sanofi
  • Trevor Wilkinson, Ph.D., Associate Director, Protein Sciences, MedImmune, Ltd.
  • Marijn van der Neut Kolfschoten, Ph.D., Senior Scientist, Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis 
  • David O’Connell, Ph.D., Director, Masters Programs in Biotechnology, School of Biomolecular & Biomedical Research, University College Dublin; Conway Institute of Biomolecular & Biomedical Research, UCD Belfield
  • Christian Löw, Ph.D., Medical Biochemistry and Biophysics, Karolinska Institute
  • Michael Akeroyd, Ph.D., DSM Biotechnology Center, The Netherlands
  • Manuel Fuentes, Ph.D., Scientist, Medicine, Centro de Investigacion Del Cancer(CIC) – University of Salamanca, CSIC
  • Paula M. Alves, Ph.D., Director, Animal Cell Technology Unit, Instituto de Biologia Experimental e Tecnológica Oeiras, Portugal
  • Jan-Willem de Gier, Ph.D., Associate Professor, Center for Biomembrane Research, Stockholm University; CSO, Xbrane Bioscience AB
  • Thomas Schmidt, Ph.D., COO, IBA GmbH
  • Athena Wong, Ph.D., Scientist, Early Stage Cell Culture, Genentech, Inc.
  • Robert Roth, Ph.D., Associate Principal Scientist, Reagents and Assay Development, AstraZeneca, Sweden
  • Peer Heine, Ph.D., European Field Applications Scientist, MaxCyte, Inc.
  • Francis Santens, Researcher, Department for Molecular Biomedical Research, VIB
  • Michaela Simcikova, Ph.D., Researcher, Prazeres Laboratory, Department of Bioengineering, Instituto Superior Técnico
  • Sofia Costa, M.S., Researcher, Centre of Biological Engineering, University of Minho
  • Stefano Gustincich, Ph.D., Associate Professor, Neurobiology, SISSA
  • Isaura Simoes, Ph.D., Molecular Biotechnology Unit, CNC/Biocant
  • Subinay Ganguly, Ph.D., Scientific Director, Team Leader CMC, Janssen R & D, Johnson & Johnson
  • Filomena Silva, Ph.D., CICS-UBI–Health Sciences Research Centre, University of Beira Interior
  • Simone Balzer, Ph.D., Faculty of Natural Sciences and Technology, Department of Biotechnology, NTNU
  • Thomas Jostock, Ph.D., Novartis Pharma AG, Basel
  • Markus Koglin, Ph.D., Associate Director, Protein Engineering, Heptares Therapeutics
  • Joerg Standfuss, Ph.D., Senior Scientist and Group Leader, Biomolecular Researcher, Paul Scherrer Institute, ETH
  • Uday Kishore, Ph.D., Director, Centre for Infection, Immunity and Disease Mechanisms, Brunel University
  • David Mead, CEO, Lucigen Corp.
  • Yoshimi Kikuchi, Ph.D., Principal Researcher, AJINOMOTO CO., INC.
  • Fabrizia Fusetti, Ph.D., Research Associate, Biochemistry, University of Groningen
  • Annie Barrand-Frelet, CNRS Researcher, CEA Saclay/iBiTec-S
  • Isabelle Green, Ph.D., Reagents and Assay Development, AstraZeneca, United Kingdom
  • Imre Berger, Ph.D., Group Leader and Principal Investigator, Structural Biology, EMBL Grenoble
  • Stefan Schmidt, Ph.D., Vice President, DSP Production, Rentschler Biotechnology
  • Anass Jawhari, Ph.D., CSO, Membrane Protein Alliance
  • Frank J.M. Detmers, Ph.D., Director, Ligand Application, Life Technologies
  • Bernd Gerhartz, Ph.D., Director, Head Protein Science CPC, Basel Novartis Institutes for BioMedical Research, Center of Proteomic Chemistry
  • Karolina Corin, Ph.D., Postdoctoral Fellow, Electrical and Information Engineering, and Molecular Medicine and Hematology, University of Witwatersrand
  • Gilles Carmel, Ph.D., Principal Scientist, Biochemistry & Structural Biology Department, Celgene
  • Marijn van der Neut Kolfschoten, Ph.D., Senior Scientist, Antibody & Vaccine Leads, Crucell Vaccine Institute